Clinical Trial Update: Shuxuening Injection for the Prevention of CVS in Patients With aSAH(SXN-CVS) [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for Shuxuening Injection aiming to prevent cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage; currently in Phase 2/Ph…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Subarachnoid Hemorrhage Aneurysmal

Drugs mentioned

• Shuxuening Injection

Snippet

Sponsor: Xiaolin Chen, MD | Conditions: Subarachnoid Hemorrhage, Aneurysmal | Phase 2, Phase 3 | Status: UNKNOWN